Scinovex
reviewTop 1% cited

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

American Journal of Respiratory and Critical Care Medicine · 2016 · Vol. 194(3) · pp. 265–275
Harold R. CollardChristopher J. RyersonTamera J. CorteGísli JenkinsYasuhiro KondohDavid J. LedererJoyce LeeToby M. MaherAthol U. WellsΚατερίνα ΑντωνίουJürgen BehrKevin M. BrownVincent CottinKevin R. FlahertyJunya FukuokaDavid M. HansellTakeshi JohkohNaftali KaminskiDong Soon KimMartin KolbDavid A. LynchJeffrey L. MyersGanesh RaghuLuca RicheldiHiroyuki TaniguchiFernando J. Martínez

Abstract

Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically significant, respiratory deterioration of unidentifiable cause. The objective of this international working group report on acute exacerbation of idiopathic pulmonary fibrosis was to provide a comprehensive update on the topic. A literature review was conducted to identify all relevant English text publications and abstracts. Evidence-based updates on the epidemiology, etiology, risk factors, prognosis, and management of acute exacerbations of idiopathic pulmonary fibrosis are provided. Finally, to better reflect the current state of knowledge and improve the feasibility of future research into its etiology and treatment, the working group proposes a new conceptual framework for acute respiratory deterioration in idiopathic pulmonary fibrosis and a revised definition and diagnostic criteria for acute exacerbation of idiopathic pulmonary fibrosis.

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchChronic Obstructive Pulmonary Disease (COPD) ResearchMedicineIdiopathic pulmonary fibrosisExacerbationEtiologyPulmonary fibrosisIntensive care medicineEpidemiologyInternal medicineFibrosisLung

MeSH terms

Acute DiseaseHumansPrognosisRisk FactorsDisease ManagementInternationalityIdiopathic Pulmonary Fibrosis
Citations
1,408
FWCI
92.50
field-weighted impact
References
92
Percentile
100%
vs. same field & year
Citations per year
Cited by
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
American Journal of Respiratory and Critical Care Medicine · 2018 · 4,017 citations
References
Acute Respiratory Distress Syndrome
JAMA · 2012 · 8,764 citations
Pirfenidone in idiopathic pulmonary fibrosis: Figure 1–
European Respiratory Journal · 2010 · 799 citations
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
American Journal of Respiratory and Critical Care Medicine · 2011 · 7,220 citations
The acute respiratory distress syndrome
Journal of Clinical Investigation · 2012 · 1,709 citations
Pirfenidone in idiopathic pulmonary fibrosis
European Respiratory Journal · 2009 · 936 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report · Scinovex